SPI Pharma
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Related Content
Ingredients
Engineering compendial mannitol for orally dispersible applications
Regulators are increasingly insisting that formulators consider patient centricity during formulation development; as such, the organoleptic properties of the final dosage form must be considered at the start
of any project, writes SPI Pharma's Graeme Macleod and Wayne Camarco
Manufacturing
Excipient innovation for enhanced patient compliance: part II
Formulation can be challenging, particularly when working with excipients such as sugar alcohols. However, a new line extension from SPI Pharma offers a solution that leverages the patient-centric benefits of mannitol while avoiding common drug development problems and simplifying manufacturing
Manufacturing
Excipient innovation for enhanced patient compliance: part I
Formulation can be challenging, particularly when working with excipients such as sugar alcohols. However, a new line extension from SPI Pharma offers a solution that leverages the patient-centric benefits of mannitol while avoiding common drug development problems and simplifying manufacturing
